Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | SSTR2 | P30874 | 2/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | NTRK1 | P04629 | 4/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | JAK2 | O60674 | 2/20 | 0.40 |
| ▸ | JAK1 | P23458 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4920459 | 0.94 | LMNA (0.51) | LMNAPOLBSSTR2CHRM3ATM | |
| SCHEMBL302840 | 0.93 | LMNA (0.60) | LMNAPOLBSSTR2CHRM3ATM | |
| SCHEMBL4914108 | 0.88 | CHRM3 (0.49) | LMNAPOLBCHRM3ATMNTRK1 | |
| SCHEMBL4919227 | 0.88 | NTRK1 (0.47) | LMNAPOLBCHRM3ATMNTRK1 | |
| SCHEMBL2350381 | 0.88 | LMNA (0.47) | LMNAPOLBCHRM3ATMNTRK1 | |
| SCHEMBL4450835 | 0.87 | LMNA (0.56) | LMNAPOLBSSTR2CHRM3ATM | |
| SCHEMBL4453763 | 0.86 | LMNA (0.52) | LMNAPOLBCHRM3ATMNTRK1 | |
| SCHEMBL303184 | 0.84 | LMNA (0.58) | LMNAPOLBCHRM3NTRK1JAK2 | |
| SCHEMBL5276665 | 0.84 | CHRM3 (0.46) | LMNAPOLBCHRM3MAPT | |
| SCHEMBL2347086 | 0.84 | LMNA (0.52) | LMNAPOLBNTRK1JAK2JAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080153707-A1 | Pyrazolecarboxanilides, Process for Their Preparation and Compositions Comprising Them for Controlling Harmful Fungi | BASF AKITENGESELLSCHAFT (DE) | 2008-06-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080153707-A1 | Pyrazolecarboxanilides, Process for Their Preparation and Compositions Comprising Them for Controlling Harmful Fungi | CBR3, C1S, PYM1 | LMNA 1073/4885POLB 2358/4885SSTR2 2379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.